SYSTEMIC SCLEROSIS
Clinical trials for SYSTEMIC SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLEROSIS trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early lung-heart drug trial stopped short
Disease control TerminatedThis study looked at whether the drug riociguat could help people with very early pulmonary hypertension, a condition where blood pressure in the lungs is too high. It included 35 adults with connective tissue disease or an inherited form. The trial was stopped early, so results …
Matched conditions: SYSTEMIC SCLEROSIS
Phase: PHASE2 • Sponsor: Heidelberg University • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC
-
COVID vaccine study in autoimmune patients halted early
Knowledge-focused TerminatedThis study aimed to measure the immune response to the COVID-19 vaccine in 78 adults with autoimmune or inflammatory diseases who take immunosuppressants or biologics. Researchers wanted to see if these medications reduce the vaccine's effectiveness. The study was terminated earl…
Matched conditions: SYSTEMIC SCLEROSIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:53 UTC
-
Tiny study on drug monitoring in scleroderma ends early
Knowledge-focused TerminatedThis study aimed to find the best level of a drug called mycophenolate mofetil (MMF) in the blood to improve skin tightness and lung function in people with systemic sclerosis. Only 2 people joined before the study was stopped early. The research was designed to see if measuring …
Matched conditions: SYSTEMIC SCLEROSIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC